Metastases hepatiques synchrones de l'adenocarcinome colo-rectal: jusqu'ou aller? A propos de 36 cas. [Synchronous hepatic metastases of colorectal adenocarcinoma: what is the course? Apropos of 36 cases]

Détails

ID Serval
serval:BIB_92C0BBA8AC77
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Metastases hepatiques synchrones de l'adenocarcinome colo-rectal: jusqu'ou aller? A propos de 36 cas. [Synchronous hepatic metastases of colorectal adenocarcinoma: what is the course? Apropos of 36 cases]
Périodique
Helvetica Chirurgica Acta
Auteur(s)
de Quay  N., Cuttat  J. F., Givel  J. C., Tevaearai  H., Chapuis  G., Albe  X., Vassilakos  P.
ISSN
0018-0181 (Print)
Statut éditorial
Publié
Date de publication
12/1989
Volume
56
Numéro
4
Pages
447-54
Notes
English Abstract
Journal Article --- Old month value: Dec
Résumé
The discovery of synchronous hepatic metastases from colorectal cancer poses a tactical problem ticklish to resolve. What are favourable circumstances for curative excision of hepatic metastases? When and how to operate them? To try to respond, we analysed a collective of 36 patients between 10. 1. 1985 and 30. 12. 1986. Of the patients staged Dukes B presenting synchronous hepatic metastases (less than 4, less than 50% of hepatic involvement by the tumour) without systemic involvement, excision at the first attempt is realizable and will be a benefit for the patient. For the others, excision is to be considered in the near future after having analysed (tumour grading and staging, CEA, ploidy of primary tumour). Patients presenting extrahepatic metastases will not benefit from hepatic resection. Surgery, associated or not to regional infusion chemotherapy is discussed.
Mots-clé
Adenocarcinoma/*secondary/surgery Colorectal Neoplasms/*surgery Combined Modality Therapy Fluorouracil/administration & dosage Humans Infusions, Intra-Arterial Liver Neoplasms/*secondary/surgery Prognosis
Pubmed
Web of science
Création de la notice
28/01/2008 9:56
Dernière modification de la notice
03/03/2018 19:32
Données d'usage